🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
\[18F\]fluorodopa (3, 4-dihydroxy-6-\[18F\]fluoro-L-phenylalanine/ FDOPA) i...
Status
Unknown
Location
Oxford University Hospitals NHS Foundation Trust
Start Date
2021-09-01
Trial ID
NCT04870580
Treatments Being Tested
It was previously shown that 18F-DOPA PET imaging results in intended manag...
Status
Completed
Location
UCLA
Start Date
2012-08-22
Trial ID
NCT01813877
Treatments Being Tested
RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled...
Status
Completed
Location
Mayo Clinic
Start Date
2010-07-26
Trial ID
NCT01165632
The purpose of this study is to evaluate the added value of PET-CT with \[1...
Status
Unknown
Location
Sourasky Medical Center
Start Date
2015-08
Trial ID
NCT02495649
Treatments Being Tested
A clinical study to investigate the effect of an investigational drug as an...
Status
Completed
Location
Research Site
Start Date
2019-08-07
Trial ID
NCT04038957
Treatments Being Tested
The goal of this study is to develop better methods of diagnosis, localizat...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2000-03-22
Trial ID
NCT00004847
Treatments Being Tested
The objective of this study is to investigate the evidence of dopaminergic ...
Status
Unknown
Location
National Taiwan Univeristy Hospital
Start Date
2017-06-12
Trial ID
NCT03973502
Treatments Being Tested
Children with congenital hyperinsulinism (CHI) have low blood sugar, and so...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2004-12
Trial ID
NCT00674440
Children with congenital hyperinsulinism (CHI) have low blood sugar, and so...
Status
Completed
Location
The Children's Hospital of Philadelphia
Start Date
2009-01
Trial ID
NCT01468454
Treatments Being Tested
The aim of the project is to develop the first alpha-synuclein (a-syn)-spec...
Status
Completed
Location
Skåne University Hospital, Dept of Neurology
Start Date
2021-07-15
Trial ID
NCT05067192